Vaccinex Faces Delisting Concerns
Ticker: VCNX · Form: 8-K · Filed: Oct 9, 2024 · CIK: 1205922
| Field | Detail |
|---|---|
| Company | Vaccinex, Inc. (VCNX) |
| Form Type | 8-K |
| Filed Date | Oct 9, 2024 |
| Risk Level | high |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.0001, $2.5 million, $35 million, $500,000 |
| Sentiment | bearish |
Sentiment: bearish
Topics: delisting, listing-standards, sec-filing
Related Tickers: VCNX
TL;DR
Vaccinex might get kicked off Nasdaq - stock could be in trouble.
AI Summary
Vaccinex, Inc. filed an 8-K on October 9, 2024, to report a notice of delisting or failure to satisfy a continued listing rule or standard. The company's common stock was previously listed on The Nasdaq Capital Market under the ticker symbol VCNX.
Why It Matters
This filing indicates potential issues with Vaccinex's continued listing on the Nasdaq, which could impact its stock liquidity and investor confidence.
Risk Assessment
Risk Level: high — A notice of delisting directly threatens the company's ability to trade on a major exchange, posing significant financial and operational risks.
Key Players & Entities
- Vaccinex, Inc. (company) — Registrant
- Nasdaq Capital Market (company) — Exchange where stock was listed
- VCNX (company) — Ticker symbol
FAQ
What specific listing rule or standard has Vaccinex, Inc. failed to satisfy?
The filing does not specify the exact rule or standard that Vaccinex, Inc. has failed to satisfy, only that it has received a notice regarding such failure.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on October 7, 2024.
What is Vaccinex, Inc.'s principal executive office address?
Vaccinex, Inc.'s principal executive offices are located at 1895 Mount Hope Avenue, Rochester, New York 14620.
What is Vaccinex, Inc.'s IRS Employer Identification Number?
Vaccinex, Inc.'s IRS Employer Identification Number is 16-1603202.
What was Vaccinex, Inc.'s former company name and when did it change?
Vaccinex, Inc.'s former name was Vaccinex Inc., and the date of the name change was November 14, 2002.
Filing Stats: 712 words · 3 min read · ~2 pages · Grade level 15.1 · Accepted 2024-10-09 16:37:59
Key Financial Figures
- $0.0001 — ich registered Common Stock, par value $0.0001 per share VCNX Nasdaq Capital Marke
- $2.5 million — ule 5550(b)(1) to maintain a minimum of $2.5 million in stockholders' equity for continued l
- $35 million — a market value of listed securities of $35 million or net income from continuing operation
- $500,000 — et income from continuing operations of $500,000 in the most recently completed fiscal y
Filing Documents
- d851320d8k.htm (8-K) — 23KB
- 0001193125-24-235251.txt ( ) — 139KB
- vcnx-20241007.xsd (EX-101.SCH) — 3KB
- vcnx-20241007_lab.xml (EX-101.LAB) — 17KB
- vcnx-20241007_pre.xml (EX-101.PRE) — 11KB
- d851320d8k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Vaccinex, Inc. Date: October 9, 2024 By: /s/ Jill Sanchez Jill Sanchez Chief Financial Officer